RenovoRx Inc (RNXT) stock news · rev $1.1M
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
This RNXT news page leads with what RenovoRx Inc filed — not a scraped headline mill.
No cached 8-K sentence for RNXT yet. We will not pad this page with generic market recap.
Latest reported RNXT revenue for 2025-12-31 was $1.1M. Net income was -$11.2M. Revenue was up 2511.6% from 2024-12-31 to 2025-12-31. RNXT currently screens at market cap $47.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RNXT stock page; for the tape open the quote page.
RNXT stock news FAQ
What are RNXT's latest revenue and net income?
Latest cached RenovoRx Inc (RNXT) revenue for Dec 31, 2025 was $1.1M. Net income was -$11.2M. Statements: https://lician.com/financials/rnxt
How did RNXT revenue change from the prior cached period?
Cached RenovoRx Inc (RNXT) revenue was up 2511.6% from $43.0K (Dec 31, 2024) to $1.1M (Dec 31, 2025). Statements: https://lician.com/financials/rnxt
What is RNXT's market cap?
RenovoRx Inc (RNXT) market cap is $47.0M on the latest cached fundamentals snapshot.
What kind of company is RNXT?
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Where is RNXT stock news listed?
Cached stock news for RenovoRx Inc (RNXT) is listed at https://lician.com/news/rnxt. Filings: https://lician.com/sec/rnxt
Not investment advice.